53493-80-4 Usage
Uses
Used in Pharmaceutical Industry:
5H-Pyrrolo[3,4-d]pyrimidine, 6,7-dihydro(9CI) serves as a key building block for the synthesis of various pharmaceuticals. Its unique structure and properties make it an essential component in the development of new drugs, contributing to the advancement of medical treatments and therapies.
Used in Organic Chemistry:
In the field of organic chemistry, 5H-Pyrrolo[3,4-d]pyrimidine, 6,7-dihydro(9CI) is utilized for its potential applications in the synthesis of organic materials. Its versatile properties allow for the creation of new compounds and materials with diverse functionalities.
Used in Drug Discovery:
5H-Pyrrolo[3,4-d]pyrimidine, 6,7-dihydro(9CI) plays a significant role in drug discovery, where its unique structure and properties are harnessed to identify and develop new therapeutic agents. Its potential in this field highlights its importance in the ongoing pursuit of innovative and effective treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 53493-80-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,9 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 53493-80:
(7*5)+(6*3)+(5*4)+(4*9)+(3*3)+(2*8)+(1*0)=134
134 % 10 = 4
So 53493-80-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3/c1-5-2-8-4-9-6(5)3-7-1/h2,4,7H,1,3H2
53493-80-4Relevant academic research and scientific papers
AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 34, (2010/11/28)
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes which are inhibitors of the dipeptidyl peptidase-IV enzyme (""DPP-IV inhibitors"") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
